{"id":3955,"date":"2017-04-16T08:50:00","date_gmt":"2017-04-16T08:50:00","guid":{"rendered":"https:\/\/www.adacyte.com\/?post_type=scientific-corner&#038;p=3955"},"modified":"2021-07-12T07:57:35","modified_gmt":"2021-07-12T07:57:35","slug":"sweets-syndrome-successfully-treated-with-granulocyte-and-monocyte-adsorption-apheresis","status":"publish","type":"scientific-corner","link":"https:\/\/www.adacyte.com\/es\/professional\/scientific-corner\/sweets-syndrome-successfully-treated-with-granulocyte-and-monocyte-adsorption-apheresis\/","title":{"rendered":"Sweet&#8217;s Syndrome Successfully Treated with Granulocyte and Monocyte Adsorption Apheresis."},"content":{"rendered":"<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Fujii+A&amp;cauthor_id=28611630\">Asami Fujii<\/a><sup>&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28611630\/#affiliation-1\">1<\/a><\/sup>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Mizutani+Y&amp;cauthor_id=28611630\">Yoko Mizutani<\/a><sup>&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28611630\/#affiliation-1\">1<\/a><\/sup>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Hattori+Y&amp;cauthor_id=28611630\">Yuki Hattori<\/a><sup>&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28611630\/#affiliation-1\">1<\/a><\/sup>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Takahashi+T&amp;cauthor_id=28611630\">Tomoko Takahashi<\/a><sup>&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28611630\/#affiliation-1\">1<\/a><\/sup>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Ohnishi+H&amp;cauthor_id=28611630\">Hidenori Ohnishi<\/a><sup>&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28611630\/#affiliation-2\">2<\/a><\/sup>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Yoshida+S&amp;cauthor_id=28611630\">Shozo Yoshida<\/a><sup>&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28611630\/#affiliation-3\">3<\/a><\/sup>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Seishima+M&amp;cauthor_id=28611630\">Mariko Seishima<\/a><sup>&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28611630\/#affiliation-1\">1<\/a><\/sup> , Case Rep Dermatol. 2017 May 22;9(2):13-18.<\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p>After the first session of GMA therapy, all symptoms including the erythematous lesions and fever were completely resolved, and serum G-CSF level was reduced. Leukocyte count, neutrophil count, serum amyloid A protein, and CRP levels were restored within normal ranges by 2 weeks. Thus, GMA therapy can successfully treat a patient with recurrent Sweet&#8217;s syndrome, potentially related to the restoration of elevated serum G-CSF levels.<\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28611630\/\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/pubmed.ncbi.nlm.nih.gov\/28611630\/<\/a><\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5465522\/pdf\/cde-0009-0013.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5465522\/pdf\/cde-0009-0013.pdf<\/a><\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>Asami Fujii&nbsp;1,&nbsp;Yoko Mizutani&nbsp;1,&nbsp;Yuki Hattori&nbsp;1,&nbsp;Tomoko Takahashi&nbsp;1,&nbsp;Hidenori Ohnishi&nbsp;2,&nbsp;Shozo Yoshida&nbsp;3,&nbsp;Mariko Seishima&nbsp;1 , Case Rep Dermatol. 2017 May 22;9(2):13-18. After the first session of GMA therapy, all symptoms including the erythematous lesions and fever were completely resolved, and serum G-CSF level was reduced. Leukocyte count, neutrophil count, serum amyloid A protein, and CRP levels were restored within normal ranges [&hellip;]<\/p>\n","protected":false},"template":"","scientific_tags":[122,147,307,123,124,125],"class_list":["post-3955","scientific-corner","type-scientific-corner","status-publish","hentry","scientific_tags-acute","scientific_tags-clinical-remission","scientific_tags-dermatology","scientific_tags-febrile","scientific_tags-neutrophilic-dermatosis-g-csf","scientific_tags-sweets-syndrome"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Sweet&#039;s Syndrome Successfully Treated with Granulocyte and Monocyte Adsorption Apheresis. - Adacyte<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/sweets-syndrome-successfully-treated-with-granulocyte-and-monocyte-adsorption-apheresis\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Sweet&#039;s Syndrome Successfully Treated with Granulocyte and Monocyte Adsorption Apheresis. - Adacyte\" \/>\n<meta property=\"og:description\" content=\"Asami Fujii&nbsp;1,&nbsp;Yoko Mizutani&nbsp;1,&nbsp;Yuki Hattori&nbsp;1,&nbsp;Tomoko Takahashi&nbsp;1,&nbsp;Hidenori Ohnishi&nbsp;2,&nbsp;Shozo Yoshida&nbsp;3,&nbsp;Mariko Seishima&nbsp;1 , Case Rep Dermatol. 2017 May 22;9(2):13-18. After the first session of GMA therapy, all symptoms including the erythematous lesions and fever were completely resolved, and serum G-CSF level was reduced. Leukocyte count, neutrophil count, serum amyloid A protein, and CRP levels were restored within normal ranges [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/sweets-syndrome-successfully-treated-with-granulocyte-and-monocyte-adsorption-apheresis\/\" \/>\n<meta property=\"og:site_name\" content=\"Adacyte\" \/>\n<meta property=\"article:modified_time\" content=\"2021-07-12T07:57:35+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/sweets-syndrome-successfully-treated-with-granulocyte-and-monocyte-adsorption-apheresis\/\",\"url\":\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/sweets-syndrome-successfully-treated-with-granulocyte-and-monocyte-adsorption-apheresis\/\",\"name\":\"Sweet's Syndrome Successfully Treated with Granulocyte and Monocyte Adsorption Apheresis. - Adacyte\",\"isPartOf\":{\"@id\":\"https:\/\/www.adacyte.com\/#website\"},\"datePublished\":\"2017-04-16T08:50:00+00:00\",\"dateModified\":\"2021-07-12T07:57:35+00:00\",\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/sweets-syndrome-successfully-treated-with-granulocyte-and-monocyte-adsorption-apheresis\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.adacyte.com\/#website\",\"url\":\"https:\/\/www.adacyte.com\/\",\"name\":\"Adacyte\",\"description\":\"Adacyte Therapeutics\",\"publisher\":{\"@id\":\"https:\/\/www.adacyte.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.adacyte.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.adacyte.com\/#organization\",\"name\":\"Adacyte\",\"url\":\"https:\/\/www.adacyte.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"contentUrl\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"width\":165,\"height\":46,\"caption\":\"Adacyte\"},\"image\":{\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Sweet's Syndrome Successfully Treated with Granulocyte and Monocyte Adsorption Apheresis. - Adacyte","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/sweets-syndrome-successfully-treated-with-granulocyte-and-monocyte-adsorption-apheresis\/","og_locale":"es_ES","og_type":"article","og_title":"Sweet's Syndrome Successfully Treated with Granulocyte and Monocyte Adsorption Apheresis. - Adacyte","og_description":"Asami Fujii&nbsp;1,&nbsp;Yoko Mizutani&nbsp;1,&nbsp;Yuki Hattori&nbsp;1,&nbsp;Tomoko Takahashi&nbsp;1,&nbsp;Hidenori Ohnishi&nbsp;2,&nbsp;Shozo Yoshida&nbsp;3,&nbsp;Mariko Seishima&nbsp;1 , Case Rep Dermatol. 2017 May 22;9(2):13-18. After the first session of GMA therapy, all symptoms including the erythematous lesions and fever were completely resolved, and serum G-CSF level was reduced. Leukocyte count, neutrophil count, serum amyloid A protein, and CRP levels were restored within normal ranges [&hellip;]","og_url":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/sweets-syndrome-successfully-treated-with-granulocyte-and-monocyte-adsorption-apheresis\/","og_site_name":"Adacyte","article_modified_time":"2021-07-12T07:57:35+00:00","twitter_card":"summary_large_image","twitter_misc":{"Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/sweets-syndrome-successfully-treated-with-granulocyte-and-monocyte-adsorption-apheresis\/","url":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/sweets-syndrome-successfully-treated-with-granulocyte-and-monocyte-adsorption-apheresis\/","name":"Sweet's Syndrome Successfully Treated with Granulocyte and Monocyte Adsorption Apheresis. - Adacyte","isPartOf":{"@id":"https:\/\/www.adacyte.com\/#website"},"datePublished":"2017-04-16T08:50:00+00:00","dateModified":"2021-07-12T07:57:35+00:00","inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.adacyte.com\/professional\/scientific-corner\/sweets-syndrome-successfully-treated-with-granulocyte-and-monocyte-adsorption-apheresis\/"]}]},{"@type":"WebSite","@id":"https:\/\/www.adacyte.com\/#website","url":"https:\/\/www.adacyte.com\/","name":"Adacyte","description":"Adacyte Therapeutics","publisher":{"@id":"https:\/\/www.adacyte.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.adacyte.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.adacyte.com\/#organization","name":"Adacyte","url":"https:\/\/www.adacyte.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","contentUrl":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","width":165,"height":46,"caption":"Adacyte"},"image":{"@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/scientific-corner\/3955","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/scientific-corner"}],"about":[{"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/types\/scientific-corner"}],"wp:attachment":[{"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/media?parent=3955"}],"wp:term":[{"taxonomy":"scientific_tags","embeddable":true,"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/scientific_tags?post=3955"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}